China Med Tech, Gaoxin Da An Partner on MDx Marketing Deal | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – China Medical Technologies said today that its wholly owned subsidiary Beijing GP Medical Technologies and Gaoxin Da An Healthcare Investments are collaborating to bring molecular diagnostic technologies to the Chinese market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.